Medicare Enrolled
Dr. Mario Curti, M.D.
Hematology & Oncology · Los Alamitos, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Curti from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Curti?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Curti
Dr. Mario Curti is a hematology & oncology specialist in Los Alamitos, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Curti performed 87,933 Medicare services across 1,600 unique beneficiaries.
Between the years covered by Open Payments, Dr. Curti received a total of $17,825 from 71 pharmaceutical and/or device companies across 875 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Curti is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 9% volume in CA
$17,825 industry payments
Medicare Practice Summary
Medicare Utilization ↗87,933
Medicare services
Top 9% in CA for hematology & oncology
1,600
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~4,628 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
57,750 | $1 | $2 |
| Pembrolizumab injection (Keytruda) | 17,200 | $41 | $96 |
| Injection, heparin sodium, (heparin lock flush), per 10 units | 7,456 | $0 | $0 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,018 | $8 | $14 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
918 | $0 | $0 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
500 | $148 | $319 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
433 | $19 | $51 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
382 | $8 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
361 | $92 | $235 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
282 | $1 | $1 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
245 | $26 | $69 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
245 | $99 | $216 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
190 | $12 | $35 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
190 | $119 | $310 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
137 | $1 | $2 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
136 | $7 | $21 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
134 | $1 | $3 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
127 | $58 | $163 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
72 | $25 | $66 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
55 | $76 | $161 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
51 | $132 | $340 |
| New patient office visit, complex (60-74 min) | 28 | $166 | $464 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
23 | $135 | $381 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
66.8% high complexity
29.7% medium
3.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$17,825
Total received (2018-2024)
Avg $2,546/year across 7 years
Top 23% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
71
Companies
875
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,330 (97.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$495 (2.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,841
2023
$2,182
2022
$1,909
2021
$2,059
2020
$741
2019
$4,153
2018
$4,939
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Gilead Sciences, Inc.
$331
Daiichi Sankyo Inc.
$222
Dendreon Pharmaceuticals LLC
$148
Merck Sharp & Dohme LLC
$105
Incyte Corporation
$104
BeiGene USA, Inc.
$93
Astellas Pharma US Inc
$89
Novartis Pharmaceuticals Corporation
$88
Janssen Biotech, Inc.
$77
Regeneron Healthcare Solutions, Inc.
$64
Bayer Healthcare Pharmaceuticals Inc.
$62
PUMA BIOTECHNOLOGY, INC.
$60
PFIZER INC.
$60
E.R. Squibb & Sons, L.L.C.
$55
Lilly USA, LLC
$53
Alexion Pharmaceuticals, Inc.
$31
Tempus AI, Inc
$29
Adaptive Biotechnologies Corporation
$27
Genentech USA, Inc.
$25
SOBI, INC
$25
Rigel Pharmaceuticals, Inc.
$21
GlaxoSmithKline, LLC.
$20
Celgene Corporation
$19
Aveo Pharmaceuticals, Inc.
$17
Eisai Inc.
$16
Top 3 companies account for 38.1% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$1,239
Incyte Corporation
$1,100
Amgen Inc.
$1,057
Lilly USA, LLC
$1,015
PFIZER INC.
$1,003
AstraZeneca Pharmaceuticals LP
$994
Daiichi Sankyo Inc.
$867
Janssen Biotech, Inc.
$852
Novartis Pharmaceuticals Corporation
$786
Celgene Corporation
$772
Pharmacyclics LLC, An AbbVie Company
$678
Gilead Sciences, Inc.
$604
Merck Sharp & Dohme Corporation
$510
Genentech USA, Inc.
$496
Takeda Pharmaceuticals U.S.A., Inc.
$473
GENZYME CORPORATION
$376
Bayer HealthCare Pharmaceuticals Inc.
$373
Janssen Pharmaceuticals, Inc
$364
Astellas Pharma US Inc
$361
Seagen Inc.
$273
TESARO, Inc.
$233
Alexion Pharmaceuticals, Inc.
$216
Puma Biotechnology, Inc.
$215
Regeneron Healthcare Solutions, Inc.
$206
Bayer Healthcare Pharmaceuticals Inc.
$194
Merck Sharp & Dohme LLC
$190
Dendreon Pharmaceuticals LLC
$189
BeiGene USA, Inc.
$150
EMD Serono, Inc.
$118
TerSera Therapeutics LLC
$118
Foundation Medicine, Inc.
$114
Exelixis Inc.
$111
Teva Pharmaceuticals USA, Inc.
$109
AbbVie, Inc.
$87
Dova Pharmaceuticals
$86
PUMA BIOTECHNOLOGY, INC.
$85
Eisai Inc.
$77
Seattle Genetics, Inc.
$73
Janssen Scientific Affairs, LLC
$61
Helsinn Therapeutics (U.S.), Inc.
$58
Clovis Oncology, Inc.
$54
Boehringer Ingelheim Pharmaceuticals, Inc.
$53
Ipsen Biopharmaceuticals, Inc
$51
Lexicon Pharmaceuticals, Inc.
$45
Aveo Pharmaceuticals, Inc.
$44
EISAI INC.
$43
Shionogi Inc
$41
Epizyme, Inc.,
$41
MEDIVATION FIELD SOLUTIONS LLC
$40
Rigel Pharmaceuticals, Inc.
$39
Genentech, Inc.
$38
Karyopharm Therapeutics Inc.
$29
Tempus AI, Inc
$29
Sumitomo Pharma America, Inc.
$28
Myovant Sciences Inc.
$28
Adaptive Biotechnologies Corporation
$27
Spectrum Pharmaceuticals Inc.
$25
SOBI, INC
$25
AVEO Pharmaceuticals, Inc.
$24
ImmunoGen, Inc.
$24
ADC Therapeutics America, Inc.
$22
Sirtex Medical Inc
$22
SERVIER PHARMACEUTICALS LLC
$22
Mirati Therapeutics, Inc.
$21
TAIHO ONCOLOGY, INC.
$21
GlaxoSmithKline, LLC.
$20
Shire North American Group Inc
$20
TG THERAPEUTICS, INC.
$18
Agios Pharmaceuticals, Inc.
$16
INSYS Therapeutics Inc
$16
Jazz Pharmaceuticals Inc.
$14
Top 3 companies account for 19.1% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ANDEXXA · Abraxane · Alecensa · Aliqopa · Aranesp · Avastin · BAVENCIO · BENDEKA · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CALQUENCE · CHANTIX · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · EMEND · EMPLICITI · ENHERTU · ERBITUX · ERLEADA · EVENITY · Elahere · Enhertu · Erleada · FOTIVDA · FOUNDATIONONE · GAUCHER-DISEASE · GAZYVA · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · Inrebic · JADENU · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MVASI · MYLOTARG · Mulpleta · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · PLUVICTO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Perjeta · Phesgo · Pomalyst · Prolia · REBLOZYL · RETACRIT · RYDAPT · Revlimid · Rezlidhia · Rubraca · SIR-Spheres Microspheres · SOLIRIS · SUTENT · SYNDROS · Somatuline Depot · Stivarga · TAGRISSO · TALVEY · TALZENNA · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · Tecentriq · Trodelvy · UKONIQ · ULTOMIRIS · VARUBI · VERZENIO · VOTRIENT · VPRIV · VYNDAQEL · VYXEOS · Vectibix · Venclexta · Vyloy · XALKORI · XARELTO · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · ZEJULA · ZOLADEX · Zevalin · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
309
Per 100K population
9.8
County median income
$113,702
Nearest hospital
UCI HEALTH - LOS ALAMITOS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Curti is a mixed practice specialist, with above-average Medicare volume (top 9% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Curti experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Curti performed 57,750 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Curti receive payments from pharmaceutical companies?
Yes. Dr. Curti received a total of $17,825 from 71 companies across 875 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Curti's costs compare to other hematology & oncology specialists in Los Alamitos?
Dr. Curti's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Curti) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Los Alamitos
Browse hematology & oncology specialists in Los Alamitos ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology